Top compounds associated with response to KRT34


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.089 0.04
mRNA decitabine CTRPv2 pan-cancer AAC -0.054 0.04
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.072 0.04
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.07 0.04
mRNA CIL70 CTRPv2 pan-cancer AAC 0.091 0.05
mRNA Erlotinib gCSI pan-cancer AAC 0.12 0.05
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.06
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.22 0.06
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.063 0.06
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.067 0.06
Download CSV